Nektar Therapeutics (NKTR) Free Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 31.42% |
| 10 | Nektar Therapeutics | 1.60 Bn | 1.04 Bn | 3.16 Mn | 5.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.40% |
| Dec 31, 2025 | -3.73% |
| Sep 30, 2025 | 16.21% |
| Jun 30, 2025 | 15.46% |
| Mar 31, 2025 | 19.09% |
| Dec 31, 2024 | 33.33% |
| Sep 30, 2024 | 24.61% |
| Jun 30, 2024 | 23.96% |
| Mar 31, 2024 | 15.62% |
| Dec 31, 2023 | 22.19% |
| Sep 30, 2023 | 8.25% |
| Jun 30, 2023 | 15.80% |
| Mar 31, 2023 | 12.81% |
| Dec 31, 2022 | 23.28% |
| Sep 30, 2022 | -3.95% |
| Jun 30, 2022 | -4.94% |
| Mar 31, 2022 | -2.29% |
| Dec 31, 2021 | -7.64% |
| Sep 30, 2021 | -12.43% |
| Jun 30, 2021 | -27.86% |
| Mar 31, 2021 | -14.37% |
| Dec 31, 2020 | -6.63% |
| Sep 30, 2020 | -37.37% |
| Jun 30, 2020 | -12.53% |
| Mar 31, 2020 | -26.89% |
| Dec 31, 2019 | -32.78% |
| Sep 30, 2019 | -38.45% |
| Jun 30, 2019 | -62.93% |
| Mar 31, 2019 | -50.62% |
| Dec 31, 2018 | -17.62% |
| Sep 30, 2018 | -59.15% |
| Jun 30, 2018 | 175.21% |
| Mar 31, 2018 | -41.92% |
| Dec 31, 2017 | -42.67% |
| Sep 30, 2017 | 58.27% |
| Jun 30, 2017 | -84.02% |
| Mar 31, 2017 | 16.67% |
| Dec 31, 2016 | -45.52% |
| Sep 30, 2016 | -11.14% |
| Jun 30, 2016 | 24.21% |
| Mar 31, 2016 | 12.97% |
| Dec 31, 2015 | -14.11% |
| Sep 30, 2015 | 15.15% |
| Jun 30, 2015 | -31.67% |
| Mar 31, 2015 | 54.99% |
| Dec 31, 2014 | 13.23% |
| Sep 30, 2014 | -26.23% |
| Jun 30, 2014 | 36.38% |
| Mar 31, 2014 | -53.05% |
| Dec 31, 2013 | 66.11% |
| Sep 30, 2013 | 17.02% |
| Jun 30, 2013 | -12.01% |
| Mar 31, 2013 | -0.25% |